OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 99,369 | 105,119 | 114,579 | NaN |
| Cost of product (excluding amortization) | 25,293 | 30,957 | 32,677 | NaN |
| Marketing expenses | 26,036 | 28,205 | 23,414 | NaN |
| Adjusted selling, general, and administrative | 27,828 | 31,884 | 26,560 | NaN |
| Depreciation and amortization | 13,318 | 13,636 | 13,698 | NaN |
| Interest expense | 7,132 | 7,551 | 7,691 | NaN |
| Interest income | 2,702 | 2,659 | 2,690 | NaN |
| Tax receivable agreement liability adjustment | NaN | 2,666 | 9,452 | NaN |
| Income tax (benefit) provision | -4,396 | 6,409 | -2,427 | NaN |
| Share-based compensation expense | 3,517 | 3,593 | 3,311 | NaN |
| Other segment items | 8,630 | 1,311 | 10,670 | NaN |
| Net (loss) income | -5,287 | -13,102 | 11,127 | -7,277 |
| Amortization of patent formulations | 2,416 | 2,705 | 2,704 | 4,576 |
| Amortization of other intangibles | 10,820 | 10,854 | 10,905 | 21,823 |
| Inventory write-off and disposal | 203 | 2,087 | 677 | 2,804 |
| Depreciation of fixed assets | 82 | 77 | 89 | 179 |
| Amortization of debt issuance costs | 287 | 287 | 288 | 3,314 |
| Deferred taxes | -4,360 | 6,016 | -3,295 | -1,444 |
| Tax receivable agreement liability adjustment | NaN | 2,666 | 9,452 | NaN |
| Share-based compensation expense | 3,517 | 3,593 | 3,311 | 6,381 |
| Acquisition-related costs in investing activities | NaN | 23 | 9,282 | NaN |
| Other | -606 | -866 | -236 | -641 |
| Accounts receivable, net | 8,757 | -20,193 | 16,995 | 17,696 |
| Inventory | 6,493 | -10,524 | -3,961 | 5,988 |
| Prepaid expenses and other current assets | -46,160 | -1,468 | 1,090 | 49,162 |
| Accounts payable | 21,041 | -15,362 | -1,407 | 14,653 |
| Accrued expenses and other current liabilities | -52,476 | 5,320 | -2,837 | 47,863 |
| Other assets and liabilities | 260 | 212 | -498 | 2,680 |
| Net cash provided by (used in) operating activities | 7,499 | 32,671 | 8,002 | 17,987 |
| Purchase of property and equipment | 146 | 109 | 71 | 151 |
| Acquisition-related costs | NaN | 46 | 10,587 | NaN |
| Purchase of intangible assets | NaN | 0 | NaN | NaN |
| Purchase and development of software | 142 | 163 | 305 | 1,174 |
| Net cash used in investing activities | -288 | -318 | -10,963 | -1,325 |
| Proceeds from exercise of stock options | 227 | 0 | 0 | 527 |
| Payment related to shares withheld to cover tax withholding obligations for options and for sars-Employee Stock Option | NaN | 0 | NaN | NaN |
| Payments for shares withheld and retired to cover tax withholding obligation for rsus | NaN | NaN | NaN | 0 |
| Payment related to shares withheld to cover tax withholding obligations for options and for sars-Stock Appreciation Rights SARS | NaN | 0 | NaN | NaN |
| Payments made pursuant to tax receivable agreement | NaN | 0 | 0 | 12,129 |
| Principal payments of 2022 term loan facility | 0 | 0 | 0 | 301,688 |
| Net cash provided by (used in) financing activities | 227 | 0 | 0 | -313,290 |
| Net increase (decrease) in cash and cash equivalents | 7,438 | 32,353 | -2,961 | -296,628 |
| Cash and cash equivalents - beginning of period | 318,731 | 286,378 | 585,967 | NaN |
| Cash and cash equivalents - end of period | 326,169 | 318,731 | 286,378 | NaN |